Logo image of RGS

REGIS CORP (RGS) Stock Fundamental Analysis

NASDAQ:RGS - Nasdaq - US7589322061 - Common Stock

24.385  +0.68 (+2.85%)

Fundamental Rating

3

Taking everything into account, RGS scores 3 out of 10 in our fundamental rating. RGS was compared to 71 industry peers in the Diversified Consumer Services industry. While RGS is still in line with the averages on profitability rating, there are concerns on its financial health. RGS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

RGS had positive earnings in the past year.
In the past year RGS has reported a negative cash flow from operations.
In the past 5 years RGS reported 4 times negative net income.
RGS had a negative operating cash flow in each of the past 5 years.
RGS Yearly Net Income VS EBIT VS OCF VS FCFRGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

RGS has a Return On Assets of 17.49%. This is amongst the best in the industry. RGS outperforms 93.75% of its industry peers.
Looking at the Return On Equity, with a value of 157.83%, RGS belongs to the top of the industry, outperforming 98.44% of the companies in the same industry.
The Return On Invested Capital of RGS (3.24%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 17.49%
ROE 157.83%
ROIC 3.24%
ROA(3y)1.6%
ROA(5y)-3.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RGS Yearly ROA, ROE, ROICRGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

RGS's Profit Margin of 45.49% is amongst the best of the industry. RGS outperforms 100.00% of its industry peers.
With a decent Operating Margin value of 8.56%, RGS is doing good in the industry, outperforming 62.50% of the companies in the same industry.
RGS's Operating Margin has improved in the last couple of years.
RGS has a better Gross Margin (99.96%) than 100.00% of its industry peers.
RGS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.56%
PM (TTM) 45.49%
GM 99.96%
OM growth 3YN/A
OM growth 5Y92.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.74%
GM growth 5Y16.96%
RGS Yearly Profit, Operating, Gross MarginsRGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1

2. Health

2.1 Basic Checks

RGS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for RGS remains at a similar level compared to 1 year ago.
Compared to 5 years ago, RGS has less shares outstanding
Compared to 1 year ago, RGS has an improved debt to assets ratio.
RGS Yearly Shares OutstandingRGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
RGS Yearly Total Debt VS Total AssetsRGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

RGS has an Altman-Z score of 0.35. This is a bad value and indicates that RGS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.35, RGS is not doing good in the industry: 60.94% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.69 is on the high side and indicates that RGS has dependencies on debt financing.
RGS's Debt to Equity ratio of 1.69 is on the low side compared to the rest of the industry. RGS is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACC0.26
WACC12.35%
RGS Yearly LT Debt VS Equity VS FCFRGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.35 indicates that RGS may have some problems paying its short term obligations.
RGS has a worse Current ratio (0.35) than 93.75% of its industry peers.
RGS has a Quick Ratio of 0.35. This is a bad value and indicates that RGS is not financially healthy enough and could expect problems in meeting its short term obligations.
RGS has a worse Quick ratio (0.35) than 90.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
RGS Yearly Current Assets VS Current LiabilitesRGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1642.82% over the past year.
RGS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 100.49% yearly.
RGS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.97%.
RGS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -28.27% yearly.
EPS 1Y (TTM)1642.82%
EPS 3YN/A
EPS 5Y100.49%
EPS Q2Q%-171.22%
Revenue 1Y (TTM)-12.97%
Revenue growth 3Y-21%
Revenue growth 5Y-28.27%
Sales Q2Q%-13.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-107.14%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RGS Yearly Revenue VS EstimatesRGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
RGS Yearly EPS VS EstimatesRGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.65, the valuation of RGS can be described as very cheap.
RGS's Price/Earnings ratio is rather cheap when compared to the industry. RGS is cheaper than 100.00% of the companies in the same industry.
RGS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.29.
RGS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 0.65
Fwd PE N/A
RGS Price Earnings VS Forward Price EarningsRGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RGS is valued cheaply inside the industry as 82.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.08
RGS Per share dataRGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RGS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REGIS CORP

NASDAQ:RGS (1/22/2025, 1:52:54 PM)

24.385

+0.68 (+2.85%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)01-29 2025-01-29
Inst Owners17.92%
Inst Owner Change0%
Ins Owners9.56%
Ins Owner Change0.92%
Market Cap55.60M
Analysts80
Price TargetN/A
Short Float %2.98%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)-5.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.65
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB N/A
EV/EBITDA 7.08
EPS(TTM)37.35
EY153.17%
EPS(NY)-2.67
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS85.82
BVpS24.74
TBVpS-52.35
PEG (NY)N/A
PEG (5Y)0.01
Profitability
Industry RankSector Rank
ROA 17.49%
ROE 157.83%
ROCE 4.1%
ROIC 3.24%
ROICexc 3.29%
ROICexgc 5.85%
OM 8.56%
PM (TTM) 45.49%
GM 99.96%
FCFM N/A
ROA(3y)1.6%
ROA(5y)-3.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y22.11%
ROICexc growth 3YN/A
ROICexc growth 5Y42.42%
OM growth 3YN/A
OM growth 5Y92.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.74%
GM growth 5Y16.96%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF N/A
Debt/EBITDA 4.71
Cap/Depr 6.63%
Cap/Sales 0.12%
Interest Coverage 0.97
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.35
F-Score5
WACC12.35%
ROIC/WACC0.26
Cap/Depr(3y)33.16%
Cap/Depr(5y)56.96%
Cap/Sales(3y)0.77%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1642.82%
EPS 3YN/A
EPS 5Y100.49%
EPS Q2Q%-171.22%
EPS Next Y-107.14%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.97%
Revenue growth 3Y-21%
Revenue growth 5Y-28.27%
Sales Q2Q%-13.7%
Revenue Next Year-6.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.92%
EBIT growth 3YN/A
EBIT growth 5Y38.21%
EBIT Next Year66.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y98.22%
OCF growth 3YN/A
OCF growth 5YN/A